Rayvio_News_Filter
$CTSO 💰
CytoSorbents announced a $6.25 million common stock financing, including a $4.0 million registered direct offering and $2.25 million of Avenue debt converted into stock, reducing total debt by $5.25 million to $12.25 million and extending maturity to July 1, 2028.
Timely market event
